Moderna
MRNA
#290
Rank
NZ$144.00 B
Marketcap
NZ$355.89
Share price
-2.17%
Change (1 day)
726.36%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$144.00 Billion

As of November 2026 Moderna has a market cap of NZ$144.00 Billion. This makes Moderna the world's 290th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$144.00 B584.11%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Moderna was reported to be:

NZ$147.19 Billion
by Nasdaq info icon info icon
NZ$147.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.188 T 725.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$518.65 B 260.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$601.64 B 317.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$1.03 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.43 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.52 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.15 B-75.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$10.67 B-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA